Larvol Delta - Acumen-Pharmaceuticals-Showcases-pTau217-Trial-Screening-Progress-in-Phase-2-ALTITUDEAD-Trial-and-Preclinical-Research-Methods-at-ADPD-2025-and-AAN-Annual-Meeting

sabirnetug IV (ACU193 IV) - Acumen Pharma

https://www.globenewswire.com/news-release/2025/05/13/3079938/0/en/Acumen-Pharmaceuticals-Reports-First-Quarter-2025-Financial-Results-and-Business-Highlights.html

May 13, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next